Does CABOZANTINIB Cause Interstitial lung disease? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Interstitial lung disease have been filed in association with CABOZANTINIB. This represents 0.5% of all adverse event reports for CABOZANTINIB.
19
Reports of Interstitial lung disease with CABOZANTINIB
0.5%
of all CABOZANTINIB reports
7
Deaths
15
Hospitalizations
How Dangerous Is Interstitial lung disease From CABOZANTINIB?
Of the 19 reports, 7 (36.8%) resulted in death, 15 (78.9%) required hospitalization, and 1 (5.3%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does CABOZANTINIB Cause?
Diarrhoea (404)
Fatigue (263)
Malignant neoplasm progression (238)
Nausea (215)
Decreased appetite (191)
Off label use (190)
Hypertension (165)
Pyrexia (162)
Vomiting (157)
Asthenia (153)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which CABOZANTINIB Alternatives Have Lower Interstitial lung disease Risk?
CABOZANTINIB vs CABOZANTINIB S-MALATE
CABOZANTINIB vs CAFFEINE
CABOZANTINIB vs CALASPARGASE PEGOL
CABOZANTINIB vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB vs CALCIFEDIOL